Clinically, observational data suggest a 19% lower glaucoma incidence in GLP-1RA-treated diabetic patients than those on other antidiabetic regimens (Figure 1, this review comprehensively analyzes the mechanistic basis of GLP-1RAs in ocular diseases, synthesizes emerging clinical and preclinical evidence, and underscores their potential to redefine therapeutic strategies for vision-threatening disorders through multi-targeted disease modification
Seguimiento: Los equipos mdicos de los balnearios suelen recomendar un seguimiento aproximadamente un mes despus, y luego cada 2-3 meses
doi: 10.1002/hep.31205 30 YounossiZMRatziuVLoombaRRinellaMAnsteeQMGoodmanZet al
Key Takeaway The NICE 2026 update highlights a shift from purely glycaemic control to early cardiovascular and renal protection, supporting the earlier use of SGLT2 inhibitors and GLP-1based therapies in appropriate patients
The molecule has to be of just the right shape to fit into the GLP-1 receptor so that it can activate it
As mentioned for CS, cabergoline is associated with a reduction in both fasting blood glucose and HbA1c (146)